REVERSAL OF MULTIDRUG RESISTANCE BY PHENOTHIAZINES AND STRUCTURALLY RELATED-COMPOUNDS

被引:112
|
作者
RAMU, A
RAMU, N
机构
[1] Department of Oncology, Hadassah Hospital, Jerusalem, 91 120
关键词
D O I
10.1007/BF00686306
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The multidrug-resistance (MDR)-reversal activity of 232 phenothiazines and structurally related compounds was tested in MDR P388 cells. Such activity was found among compounds exhibiting two ring structures (phenyl, cyclopentyl, cyclohexyl, thienyl or 5-norbornen-2-yl but not pyridinyl) linked by a variety of bridge types and possessing a secondary or tertiary amine group. Among 192 such compounds, 31.8% displayed good activity (MDR-reversal ratio, greater-than-or-equal-to 10) and 8.3%, outstanding activity (MDR-reversal ratio, greater-than-or-equal-to 30). In a subgroup comprising 56 compounds with a carbonyl residue, 4 with sulfuryl residue and 1 with thienyl residue, 42.7% showed good activity and 18%, outstanding activity. The contribution of these residues to the MDR-reversal activity was particularly evident among compounds containing a cyclic tertiary amine. Among 49 such compounds, 51% displayed good activity and 20.4%, outstanding activity, whereas among the 85 compounds lacking such groups, only 31.8% showed good activity and 4.7%, outstanding activity. Enhancement of this activity by the carbonyl group is also obtained when the latter is part of an amide bond of a tertiary amine. As compounds with a carbonyl group located on the rings, on the bridge to the amine group or beyond the amine are efficient MDR reversers, it seems that the exact molecular location of the carbonyl group is not critical for the elicitation of this activity
引用
收藏
页码:165 / 173
页数:9
相关论文
共 50 条
  • [22] COMPARISON BETWEEN PHENYLPROPANOLAMINE AND STRUCTURALLY RELATED-COMPOUNDS ON GASTRIC TRANSIT IN THE RAT
    HULL, KM
    ZANZILLARI, R
    MAHER, TJ
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 46 (02) : 411 - 414
  • [23] Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds
    Molnár, J
    Szabo, D
    Mándi, Y
    Mucsi, I
    Fischer, J
    Varga, A
    König, S
    Motohashi, N
    ANTICANCER RESEARCH, 1998, 18 (4C) : 3033 - 3038
  • [24] REVERSAL OF MULTIDRUG RESISTANCE
    KAYE, SB
    CANCER TREATMENT REVIEWS, 1990, 17 : 37 - 43
  • [25] REVERSAL OF MULTIDRUG RESISTANCE
    CHABNER, BA
    WILSON, W
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (01) : 4 - 6
  • [26] Phenothiazines as potent modulators of yeast multidrug resistance
    Kolaczkowski, M
    Michalak, K
    Motohashi, N
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 22 (03) : 279 - 283
  • [27] OCHRATOXIN PRODUCTION BY ASPERGILLUS-OCHRACEUS AS AFFECTED BY METHIONINE AND STRUCTURALLY RELATED-COMPOUNDS
    LISKER, N
    PASTER, N
    CHET, I
    CANADIAN JOURNAL OF MICROBIOLOGY, 1983, 29 (05) : 536 - 540
  • [28] TRIANIONS BY REGIOSELECTIVE AND STEREOSELECTIVE LITHIATION OF DIALLYLAMINES AND STRUCTURALLY RELATED-COMPOUNDS - SYNTHETIC APPLICATIONS
    BARLUENGA, J
    GONZALEZ, R
    FANANAS, FJ
    YUS, M
    FOUBELO, F
    JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1994, (08): : 1069 - 1077
  • [29] EXPERIMENTAL CONVULSIONS IN RATS INDUCED BY INTRAVENTRICULAR ADMINISTRATION OF KYNURENINE AND STRUCTURALLY RELATED-COMPOUNDS
    PINELLI, A
    OSSI, C
    COLOMBO, R
    TOFANETTI, O
    SPAZZI, L
    NEUROPHARMACOLOGY, 1984, 23 (03) : 333 - 337
  • [30] INHIBITION OF TYPE-A MONOAMINE-OXIDASE BY METHYLQUINOLINES AND STRUCTURALLY RELATED-COMPOUNDS
    NAOI, M
    NAGATSU, T
    JOURNAL OF NEUROCHEMISTRY, 1988, 50 (04) : 1105 - 1110